SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-18-002483
Filing Date
2018-06-05
Accepted
2018-06-05 07:01:06
Documents
4
Period of Report
2018-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 4616
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5500
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 7430
4 GRAPHIC trilogo.jpg GRAPHIC 5076
  Complete submission text file 0001062993-18-002483.txt   25649
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 18880061
SIC: 2834 Pharmaceutical Preparations